The QualityStocks Daily Stock List
- Bionik Laboratories Corp. (BNKL)
- GP Solutions, Inc. (GWPD)
- HIVE Blockchain Technologies Ltd. (HVBTF)
- Interlink Electronics, Inc. (LINK)
- Item 9 Labs Corp. (INLB)
- OceanaGold Corporation (OGDCF)
- RIWI Corp. (RWCRF)
- Prize Mining Corporation (PRZFF)
- Innovation Pharmaceuticals, Inc. (IPIX)
- Lithium Exploration Group, Inc. (LEXG)
- DSG Global, Inc. (DSGT)
- KinerjaPay Corp. (KPAY)
- Provision Holding, Inc. (PVHO)
- WRIT Media Group, Inc. (WRIT)
Bionik Laboratories Corp. (BNKL)
NetworkNewsWire, Zacks, Wallet Investor, MarketWatch, Real Investment Advice, TradingView, InvestorsHub, Equities, Market Screener, Marketbeat, Business Insider, Business Wire, Barchart, Last10k, 4-Traders, and Stockhouse reported beforehand on Bionik Laboratories Corp. (BNKL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Bionik Laboratories Corp. concentrates on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home. A robotics company, Bionik has a portfolio of products focused on upper and lower extremity rehabilitation for stroke and other mobility-impaired patients. This includes three products on the market and four products in different stages of development. Bionik Laboratories is headquartered in Toronto, Ontario and the Company lists on the OTC Markets’ OTCQB.
Resulting from pioneering research at the Newman Laboratory for Biomechanics and Human Rehabilitation at the Massachusetts Institute of Technology (MIT), the InMotion Robots provide effective, patient-adaptive therapy, intended to restore upper-extremity motor control for a broad array of neurological conditions and recovery stages. This includes early recovery from acute stroke.
InMotion Robots also provide objective evaluation assessments intended to measure and report the patient’s level of motor impairment and progress during the course of therapy. A home version of the InMotion upper-extremity technology is in development.
Bionik Laboratories announced in January 2019 the commercial launch of its newest generation InMotion ARM/HAND™ robotic system for clinical rehabilitation of stroke survivors and those with mobility impairments due to neurological conditions. The Company showcased the new technology for the first time at the American Physical Therapy Association Combined Sections Meeting (APTA CSM) that took place January 23-26, 2019 at the Walter E. Washington Convention Center in Washington, D.C.
Bionik Laboratories has completed the transition to outsourcing of the production of the newest generation InMotion ARM/HAND™ robotic system, as well as the InMotion ARM™, to its manufacturing partner Cogmedix, in Massachusetts. Bionik Laboratories is also continuing the development of a lower-limb assistive exoskeleton for individuals with impaired mobility through an earlier announced manufacturing partnership with Wistron Corporation.
In May, Bionik Laboratories announced the completion of a landmark Robot Assisted Training for the Upper Limb after Stroke (RATULS) trial using Bionik’s InMotion Robotic Therapy Systems. Results of the RATULS trial were presented at the European Stroke Organisation Conference (ESOC) in Milan, Italy on May 22, 2019. They were published in the Lancet Online Journal on the same day.
The purpose of the study was to compare clinical effectiveness of robot assisted training, enhanced upper limb therapy, and usual care for patients with moderate or severe upper limb functional limitation. The RATULS trial started in 2014 and was completed the end of 2018.
Dr. Eric Dusseux, Bionik Laboratories’ Chief Executive Officer, said, “We are pleased that the RATULS trial confirmed the finding of previous research studies which demonstrated that robot-assisted therapy improved upper limb impairment when compared with conventional care methods for stroke victims. The trial’s finding that robotic therapy is the only therapy to statistically maintain a significant impairment advantage at six months after treatment is a strong signal that robotic therapy is critical for achieving positive patient outcomes.”
Bionik Laboratories Corp. (BNKL), closed Monday's trading session at $3.19, even for the day, on 100 volume. The average volume for the last 3 months is 71 and the stock's 52-week low/high is $0.05/$100.00.
GP Solutions, Inc. (GWPD)
Penny Stock Hub, Grassnews, News to Watch, OTC Markets, Investors Hangout, Otc.watch, Stockwatch, TradingView, Wall Street Reporter, Cannabis Business Executive, Wallet Investor, InvestorsHub, and Dividend Investor reported earlier on GP Solutions, Inc. (GWPD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
GP Solutions, Inc. is a foremost developer of automated micro-farms. The Company developed "GrowPods", which are portable, modular, automated indoor micro-farms. They provide optimum conditions for plant cultivation with total environmental control. The Company produces state-of-the -art, custom container farms for farmers, growers, restaurants, hotels, casinos, and entrepreneurs, and investors throughout North America. GP Solutions lists on the OTC Markets. The Company is based in Corona, California.
GP Solutions provides a state of-the-art, environmentally optimized growing system for growing high quality specialty crops, specifically leaf crops. This includes numerous varieties of herbs. The focus is to do so with the Grow Pod, employing the most up-to-date technology in soil-less, hydroponic growing technology.
This is to foster superior quality, high crop yields in a totally secure and monitored environment. This creates a year around growing system in any location worldwide, as well as a predictable yield harvest after harvest. The controlled environment of a GrowPod facility covers 320 square feet. It will have a yearly production capability of up to four times that of outdoor growing methods considerably boosting grower profitability.
GrowPod is a modular, stackable and mobile vertical growing environment. They are purposely engineered to maximize yield and automation. They are a completely insulated, food-grade shipping container specifically modified to provide the optimum controlled environment for growing a broad array of horticultural and agricultural products in all environments and climates.
This past May, GP Solutions announced it installed one of its Growth Chambers at the University of California, Riverside. The growth chamber will be used for agricultural and horticultural research at the University. The Company developed the specialized system to meet the need for a large walk-in growing system that offers researchers a precision-controlled environment to conduct sophisticated research at laboratories and universities across the nation.
Recently, GP Solutions announced it is now offering financing to provide businesses with a fast, low-cost path to start growing profitable herbs and vegetables with the advanced "GrowPod" system. The Company’s new financing plans offer an assortment of options for businesses to enter the highly profitable world of micro-farming. GrowPods can be customized to provide the perfect environment for a broad spectrum of cash-crops, herbs and vegetables.
GP Solutions, Inc. (GWPD), closed Monday's trading session at $2.75, even for the day, on 258 volume with 3 trades. The average volume for the last 3 months is 413 and the stock's 52-week low/high is $1.03999996/$39.00.
HIVE Blockchain Technologies Ltd. (HVBTF)
Micro Small Cap, TipRanks, Blockchain Stocks, FXStreet, Smarter Analyst, Crypto141, Invest Tribune, Stockwatch, 4-Traders, Market Screener, InvestorsHub, Dividend Investor, Wallmine, Investors Hangout, YCharts, Trading View, Insider Financial, Stockhouse, and Simply Wall St reported beforehand on HIVE Blockchain Technologies Ltd. (HVBTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
HIVE Blockchain Technologies Ltd. is a company building a bridge from the blockchain sector to traditional capital markets. It is strategically partnered with Genesis Mining Ltd. to build the next generation of blockchain infrastructure. HIVE’s mission is to hasten the development of the blockchain sector via traditional capital markets and create long-term shareholder value. OTCQX-listed, HIVE Blockchain Technologies has its corporate office in Vancouver, British Columbia.
HIVE has an exclusive arrangement with Genesis Mining to operate its data centers under a Master Service Agreement. The data centers will be monitored with Genesis Hive, which is Genesis Mining's proprietary software tool for large-scale mining, to automatically optimize chip temperatures and power consumption for maximal coin production.
HIVE’s deployments provide shareholders with exposure to the operating margins of digital currency mining and an increasing portfolio of crypto-coins. The Company owns state-of-the-art GPU-based digital currency mining facilities in Iceland and Sweden that produce newly minted digital currencies such as Ethereum continuously and also a cloud-based ASIC-based capacity that produces newly minted digital currencies such as Bitcoin.
Regarding the Iceland Cryptocurrency Mining Project, HIVE’s launch transaction involved the acquisition of an initial state-of-the-art blockchain infrastructure facility in Iceland from Genesis Mining. The facility produces mined cryptocurrency around the clock. Assembly of the facility, which uses innovative computing components and infrastructure design, was completed in May of 2017. In Sweden, HIVE's GPU facilities were completed in April of last year. They are equipped with custom Genesis A2 mining rigs.
HIVE Blockchain Technologies launched the operation of an additional 100 PH of cloud-based ASIC Bitcoin mining on December 1, 2018. This brings its digital currency mining footprint to a total of 24.2 MW of GPU mining and 300 PH of ASIC capacity.
Recently, HIVE Blockchain Technologies and Genesis Mining announced that they reached a settlement agreement that positively resolves prior misunderstandings and disagreements. The agreement was reached with an emphasis on initiatives that improve communication, transparency and mutually beneficial cooperation between Genesis and HIVE. Operationally, HIVE and Genesis will reboot HIVE's 20.4 Megawatt (MW) facility in Sweden with 14,000 GPUs mining Ethereum. Moreover, HIVE will continue to receive 300 Petahash (PH) of cloud-based ASIC Bitcoin mining capacity from Genesis.
This month, HIVE Blockchain Technologies announced that it restarted mining operations in Sweden with power again running through the facility. In addition, the Company is continuing to conduct mining operations in Iceland. The reboot of the Swedish facility comes as Ethereum pricing continues to show strength, while electricity prices in Sweden have dropped by 70 percent since the beginning of 2019. HIVE will continue to optimize its equipment during this transition period. The Company continues to receive 300 Petahash (PH) of cloud-based ASIC Bitcoin mining capacity from Genesis Mining.
HIVE Blockchain Technologies Ltd. (HVBTF), closed Monday's trading session at $0.28, off by 6.1977%, on 479,029 volume with 147 trades. The average volume for the last 3 months is 580,625 and the stock's 52-week low/high is $0.170000001/$0.796500027.
Interlink Electronics, Inc. (LINK)
MacroTrends, Street Insider, AI Stock Finder, Stockhouse, Last10k, Simply Wall St, TMX Money, Investing.com, MarketBeat, Stockopedia, and InvestorsHub reported previously on Interlink Electronics, Inc. (LINK), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Interlink Electronics, Inc. is a world-leading trusted advisor and technology partner in the advancing world of human-machine interface (HMI) and force-sensing technologies. The Company has led the printed electronics industry in its commercialization of its patented Force-Sensing Resistor (FSR®) technology, which has enabled strong and reliable HMI solutions. Established in 1985, Interlink Electronics has its corporate office in Westlake Village, California.
The Company also serves its customer base from its worldwide research and development center in Singapore, its printed-electronics manufacturing facility in Shenzhen, China, and its worldwide distribution and logistics center in Hong Kong. In addition, Interlink Electronics maintains technical and sales offices in Japan and at varied locations in the U.S.
The Company delivers multi-platform sensor solutions to the world's major OEMs (Original Equipment Manufacturers), Tiers and Integrators. Its solutions center on handheld user input, menu navigation, cursor control, and other intuitive interface technologies for the world's foremost electronics manufacturers. Interlink has a proven record of accomplishment of supplying HMI solutions for mission-critical applications in a broad variety of markets. These include, but are not limited to, consumer electronics, automotive, industrial, as well as medical devices.
Interlink’s corporate strategy is built on the identification and qualification of unique HMI technologies, and using them intelligently to deliver high value-added solutions to its customers. The Company’s product development teams skilled capabilities are in concept definition, rapid prototyping, hardware and firmware development and integration support.
Interlink’s products include Force Sensing Resistor® technology, Force sensing linear potentiometers (FSLP), and integrated mouse modules & pointing solutions. The Company was founded on the invention and commercialization of the Force Sensing Resistor®. As Interlink transitions from an FSR® sensor supplier to an HMI solution provider, it is pursuing and embracing pioneering sensor technology platforms. Interlink is working to advance the HMI and Force-Sensing Technology Revolution™.
In May, Interlink Electronics announced its financial results for Q1 2019. GAAP Net Loss for the quarter was ($314) thousand or ($0.05) per share. Both reflect a substantial decrease from the prior year’s results. Revenue in Q1 of 2019 decreased roughly 44 percent to $1.5 million from $2.6 million in the same prior year period. This was mainly because of market challenges existing in many of the industries the Company serves. Gross Margin declined to 48 percent from 55 percent because of the drop in Revenues, as less Revenue was available to cover fixed costs and production overhead costs.
Mr. Steven N. Bronson, Interlink Electronics’ Chief Executive Officer, said, “We had a very solid quarter in our Medical market, with sturdy sales and pipeline that remains robust and will continue to be a source for growth, although at a slower pace. These flat but encouraging results were more than offset by the anticipated year-over-year declines in Automotive and Industrial markets related to a sharp drop-off in shipments to some of our largest customers. Given the weaker than expected demand across all markets, we have implemented a variety of countermeasures to adjust our cost structure and limit the impact of the softness going forward.”
Interlink Electronics, Inc. (LINK), closed Monday's trading session at $2.00, even for the day, on 2,842 volume with 3 trades. The average volume for the last 3 months is 984 and the stock's 52-week low/high is $1.62/$5.34959983.
Item 9 Labs Corp. (INLB)
OTC Markets, Pot Stock News, Tip Ranks, Market Screener, Financial Content, Stockhouse, Wallet Investor, GlobeNewswire, Invest Tribune, Financial Buzz, Investors Hangout, Trading View, Stockwatch, Dividend Investor, GuruFocus, Equity Clock, CannabisMarketCap, Business Insider, and InvestorsHub reported earlier on Item 9 Labs Corp. (INLB), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Item 9 Labs Corp. is a leader in comfortable cannabis health solutions for the contemporary consumer. It brings best of industry practices to markets across the country via cultivation and production, distinct retail environments, licensing services, and varied product groups. The Company caters to different medical cannabis demographics. Item 9 Labs has its head office in Phoenix, Arizona. It also has medical cannabis operations in numerous U.S. markets.
The Company’s asset portfolio includes Dispensary Permits, Dispensary Templates, and Strive Life. Dispensary Permits is its consulting firm. It specializes in strategic license application and compliance. Dispensary Templates, a subdivision of Item 9 Labs, is a technology platform with a wide-ranging digital library of licensing and business planning resources.
Strive Life is a turnkey dispensary model for the retail sector. It improves the patient experience with consistent and first-rate service, high-end design, and precision-tested products. At present, it is undergoing implementation in Arizona and North Dakota. Additionally, Item 9 Labs has created complementary brands - Item 9 Labs and Strive Wellness - to channel consumer diversity.
Propriety delivery platforms include the Apollo Vape and Pod system, and also a cutting-edge intra-nasal device. Item 9 Labs has received manifold accolades for its medical-grade flower and concentrates.
By the end of this year, Item 9 Labs will be managing cultivation, processing, distribution, and dispensary operations in up to ten U.S. markets. Present facilities include distribution and processing operations - Strive Wellness of Ohio and Strive Wellness of Nevada, and a dispensary - Strive Life North Dakota.
The Company’s plan includes completing the 20,000 square-foot construction of the Strive Wellness of Nevada processing facility in Q4 of this year. Moreover, it plans on continuing expansion of its distribution and sales network.
Medical marijuana dispensary Strive Life Grand Forks, a partner following the Company’s Strive Life business model and brand, officially opened on Wednesday, May 22, 2019, at 1809 13th Avenue North, in Grand Forks, North Dakota. This operation will offer a diverse inventory of patient-focused products. Strive Life Grand Forks implements medical marijuana dispensary best practices from across the U.S. and internationally.
Last month, Item 9 Labs announced that its expanded Arizona cultivation and manufacturing facility received State approval to operate. The custom 10,000 square-foot construction passed inspections on June 4, 2019 and production has started. This new building features technology improvements in all areas of the grow process. This includes advanced irrigation, lighting, HVAC, as well as upgraded environmental controls.
Today, Item 9 Labs announced the launch of its new corporate site and brand image. The logo and style updates strengthen its national market share positioning under one unified identity. Chief Executive Officer, Sara Gullickson, stated, “Item 9 Labs has expanded significantly in the past year and it was important for us to reshape our corporate branding to reflect this evolution. Our new identity echoes our dynamic and innovative attributes that have set us apart in a highly competitive market.”
Item 9 Labs Corp. (INLB), closed Monday's trading session at $3.50, even for the day, on 70 volume with 1 trade. The average volume for the last 3 months is 4,419 and the stock's 52-week low/high is $1.50/$8.39999961.
OceanaGold Corporation (OGDCF)
Forex Stock News, MarketBeat, AASTOCKS.com, Wallmine, Northern Miner, Investing.com, CapitalCube, Resource World, TradingView, TeleTrader, 4-Traders, Seeking Alpha, and Wallet Investor reported earlier on OceanaGold Corporation (OGDCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
OceanaGold Corporation is a multinational gold producer with international operating, development, as well as exploration experience. The Company’s operating assets include the Didipio Mine on Luzon Island in the Philippines; the Macraes Operations in the South Island of New Zealand; the Waihi Gold Mine in the North Island of New Zealand; and the Haile Gold Mine in South Carolina, USA. OceanaGold’s shares trade on the OTC Markets. The Company is headquartered in Melbourne, Australia. Additionally, its business is supported by its Americas office in Denver, Colorado; a technical and projects office in Brisbane, Australia; and an information technology and finance office in Singapore.
OceanaGold has a significant pipeline of organic growth and exploration opportunities in the Americas and Asia-Pacific. The Company has a track record of converting discoveries into production.
OceanaGold developed out of the gold-production assets of Gold and Resource Developments Limited in 2003 with a varied portfolio of assets in the South Island of New Zealand. In 2006, the Company acquired the Didipio Project in the Philippines via the merger with Climax Mining. In 2015, OceanaGold expanded its presence in New Zealand with the acquisition of the Waihi Gold Mine in the North Island, and also took ownership of the Haile Gold Mine via the takeover of Romarco Minerals, Inc. In addition, OceanaGold made a strategic investment in TSXV-listed Gold Standard Ventures.
This year, OceanaGold started a Joint Venture (JV) with Renaissance Gold for the Spring Peak and Fat Lizard gold projects in Nevada, and received permits for Martha Underground Expansion project at Waihi. It also reported an initial high-grade resource for the Wharekirauponga Exploration Project in New Zealand. Furthermore, the Company started a JV with American Pacific Mining Corp. for the Tuscarora Gold Project in Nevada, and began a JV with Rio de Oro S.A. for the Pedernales and Santa Teresita projects in Argentina.
Yesterday, OceanaGold’s Macraes Operations in the South Island of New Zealand celebrated the five millionth ounce of gold poured at the operation. Macraes General Manager, Mr. Matthew Hine, said the five million-ounce milestone was a tribute to the commitment and innovation of its workforce and the continuing support of contractors and the broader Otago community. OceanaGold has undertaken 28,000 meters of exploration drilling at Macraes in the first half of this year. Its intention is to further extend the operation’s mine life. Most of that drilling has centered on the Golden Point target that recent announcements highlight as having Open Pit and Underground potential.
OceanaGold Corporation (OGDCF), closed Monday's trading session at $3.08, up 0.917431%, on 1,500 volume with 4 trades. The average volume for the last 3 months is 949 and the stock's 52-week low/high is $2.44000005/$3.74.
RIWI Corp. (RWCRF)
Stock News Now, Macroaxis, TeleTrader, Research Pool, Investorx, TMX Money, Dividend Investor, Stockwatch, Wallet Investor, TradingView, Before It’s News, Stockhouse and Proactive Investors reported previously on RIWI Corp. (RWCRF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
RIWI Corp. is a worldwide trend-tracking and prediction technology enterprise. The Company, on a monthly or annual subscription basis, offers its clients tracking surveys, continuous risk monitoring, predictive analytics, and ad effectiveness tests in all countries. RIWI has offices in Toronto, Ontario; Vancouver, British Columbia; and Chelsea, London. The Company lists on the OTC Markets.
RIWI invented global, continuous, agile and privacy-compliant data collection. It reaches disengaged populations online. It is anonymous and secure, safe for respondents, and no personally identifiable information is ever captured. It features randomized recruitment and response, as well as a continuous, real-time data feed to identify changes.
Fundamentally, the Company’s technology provides continuous predictive data using online surveys. RIWI delivers real-time analytics-infused insights to the finance, humanitarian aid, and security sectors by way of data dashboards. At any time, its clients can download all raw data into MS Excel or SPSS.
RIWI offers global surveys, predictive analytics, message testing, and risk monitoring anywhere worldwide via long-term agreements and monthly subscriptions. The Company’s data-on-demand offerings include time-series analysis; predictions about major geopolitical events that significantly influence equities and commodities markets; and real-time analytics-infused insights about fast-changing investor sentiment and technology trends.
In October of 2018, RIWI announced that one of its finance clients, a top-10 bank in the world as measured by assets under management, awarded RIWI a third contract. The value of this contract is US$543,000. RIWI earns recurring revenue with the bank pursuant to a three-year long-term agreement signed in August of 2017.
Mr. Neil Seeman, Chief Executive Officer of RIWI, said in October 2018, “Our unwavering commitment to client delivery excellence ensures that a growing proportion of RIWI’s work in all of its business lines –global finance, global security, humanitarian aid, and global consumer goods – is now recurring revenue under long-term agreements.”
Last month, RIWI announced that it signed a contract expansion with a G7 government agency. The one-year expansion of the agreement is valued at US$780,000. RIWI has started work on the new contract.
RIWI Corp. (RWCRF), closed Monday's trading session at $1.95826, off by 10.5817%, on 9,500 volume with 2 trades. The average volume for the last 3 months is 3,328 and the stock's 52-week low/high is $0.80610001/$2.49720001.
Prize Mining Corporation (PRZFF)
Investing News, The Street, Junior Mining Network, Science of Stocks, Small Cap Power, Stockhouse, Stock Market Watch, Market News Updates, Barchart, Wallet Investor, 4-Traders, OTC Markets, Business Insider, Trading View, and Penny Stock Hub reported previously on Prize Mining Corporation (PRZFF), and we also report on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Prize Mining Corporation explores for and develops mineral properties. The Company’s flagship project is the Manto Negro Copper Project (Coahuila, Mexico). Additionally, it has its Kena & Daylight Gold project. An exploration stage company, Prize Mining is based in Calgary, Alberta.
The Manto Negro Copper Project has sedimentary stratabound oxidized and reduced “Red Bed type” copper deposits. The Manto Negro property consists of 17,659 hectares. It includes more than 35 known occurrences of copper mineralization.
Prize Mining received the NI 43-101 Technical Report for the Manto Negro property in Coahuila, Mexico from geological consultants, Norwest Corporation of Calgary, Alberta. The Technical Report includes a review of the regional and local geology, mineralization types and grades, exploration history and results, overall mineral potential and recommendations for more work. The report does not include any estimate of mineral resources nor reserves.
The Kena & Daylight Gold project is a large property with first-rate infrastructure. This Property comprises 9,000 hectares in southeastern British Columbia. The Property is 10 kilometers from the Town of Nelson. The Gold Mountain Zone and Kena Gold Zone are a porphyry gold deposit with high grade zones.
The Kena Property has an NI 43-101 resource of an indicated 481,000 ounces of gold and an inferred 1,318,000 ounces of gold. The Daylight claims have four historical producing mines with grades as high as 37 g/t gold. The Company’s focus on the Daylight Property is on four large gold-bearing targets.
Prize Mining announced this past December that step-out diamond drill holes at the Pilar Grande area of the Manto Negro Copper Project continues to intersect copper-silver mineralization. Drilling at the El Granizo site encountered complex faulting that is yet to be completely interpreted as to the impact on mineralization.
Also in December, the Company reported results from the Phase I and II diamond drill programs from the Kena Gold Project, positioned in the highly prospective Kootenay Boundary area near Nelson, British Columbia. The focus of the exploration program at the Kena Gold Project has been on the Toughnut Property. Drilling on Toughnut has intersected significant near surface gold mineralization. The higher grade intercepts demonstrate the potential for a much larger gold system on Prize Mining’s property.
Recently, Prize Mining provided an update on the results and success of its Phase 1 diamond drilling program at the Manto Negro Copper Project.
Mr. Michael McPhie, Prize Mining’s President and Chief Executive Officer, said, "We are very pleased to announce the completion of and results from our Phase 1 exploration drilling program at the Manto Negro Copper Project. We have tested just a small part of our 18,000 hectare property that contains some 35 surface copper showings over a 40 kilometer trend. These results provide us with confidence in the scale, grade and potential of this district size property and will guide our focus in the Phase 2 program that will begin in the weeks ahead."
Prize Mining Corporation (PRZFF), closed Monday's trading session at $0.0206, up 51.4706%, on 39,387 volume with 5 trades. The average volume for the last 3 months is 14,144 and the stock's 52-week low/high is $0.012684999/$0.154699996.
Innovation Pharmaceuticals, Inc. (IPIX)
Streetwise Reports, Real Investment Advice, Simply Wall St, Stockhouse, The OTC Reporter, Tip Ranks, Insider Financial, Stockopedia, Emerging Growth, Stockdigest Report, MarketWatch, Wallet Investor, Investors Hangout, Barchart, and InvestorsHub reported on Innovation Pharmaceuticals, Inc. (IPIX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Innovation Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is developing innovative therapies in many diseases and its belief is that it has a first-rate portfolio of first-in-class lead drug candidates. The Company is now advancing them toward market approval, while actively seeking strategic partnerships. Innovation Pharmaceuticals is based in Beverly, Massachusetts.
The Company has established research collaborations with world-renowned research institutions in the United States and Europe. These include MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.
Innovation Pharmaceuticals’ anti-cancer drug is Kevetrin. It successfully concluded a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. The Company has started a Phase 2 study in Ovarian Cancer.
Innovation has its Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention of OM in patients with head and neck cancer. Brilacidin - a defensin mimetic compound - has shown in an animal model to lessen the occurrence of severe ulcerative Oral Mucositis (OM) by more than 94 percent in comparison to placebo.
Brilacidin completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infection, or ABSSSI. Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the Food and Drug Administration (FDA)-approved seven-day dosing regimen of daptomycin.
Innovation’s Psoriasis drug candidate is Prurisol. It completed a Phase 2 trial and the Company has launched a Phase 2b study. Prurisol is a small molecule. It acts by way of immune modulation and PRINS reduction.
Recently, Innovation Pharmaceuticals provided a corporate update highlighting business development and clinical pipeline priorities across its first-in-class drug candidates, Brilacidin, Prurisol and Kevetrin.
Mr. Leo Ehrlich, Innovation Pharmaceuticals’ Chief Executive Officer, said, “A successful End-of-Phase 2 FDA meeting for our Brilacidin-Oral Mucositis asset, or positive results from our Phase 2b Prurisol trial in psoriasis—either outcome we believe would open up enormous possibilities for our shareholders. We look forward to updating shareholders on these, and other company developments, as we continue to lay a strong scientific foundation upon which future successes can be built.”
Innovation Pharmaceuticals, Inc. (IPIX), closed Monday's trading session at $0.18, up 45.7136%, on 2,347,575 volume with 365 trades. The average volume for the last 3 months is 592,604 and the stock's 52-week low/high is $0.07/$0.600000023.
Lithium Exploration Group, Inc. (LEXG)
MicroCap Daily, Insider Financial, Penny Stock Tweets, Epic Stock Picks, OTC Markets, and The Wolf of Penny Stocks reported on Lithium Exploration Group, Inc. (LEXG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Lithium Exploration Group, Inc. concentrates on the acquisition and development potential of lithium brines and other precious metals that demonstrate high probability for near-term production. The Company is currently focusing on sales and distribution of the Sonic Cavitation Ltd. technology and the acquisition of oil and gas related assets in the U.S. and Canada. An exploration and development company, Lithium Exploration is based in Phoenix, Arizona.
Lithium Exploration’s commitment is to developing assets and technologies in Oil & Gas, and Waste Treatment. The Company is developing an ultrasonic generator for different field applications in the oil and gas industry. The technology provides lower cost, low energy solutions to many pre-existing processes within these markets.
Lithium Exploration’s Oil & Gas assets consist of the White Top Field. This asset is positioned onshore in Southwest Louisiana. The cumulative production to-date is 32 million barrels. Current production is 120 barrels of oil per day.
The Company has partnered with Sonic Cavitation (SonCav) to develop SonCav's patented technology for the treatment of hydrocarbon fluid stocks and waste water. The SonCav generator is skid mounted for easy mobility to even the most remote field locations. At present, SonCav is field ready for customers across North America. SonCav runs off of 3 phase electricity. It produces no on-site emissions.
Lithium Exploration announced this past March that its partners in the White Top project were making major progress on the preparations to close on the eventual acquisition of the field and development strategy. The seismic data has been totally processed.
Lithium Exploration stated that it continues to impress all parties that have looked at it. The Company has a royalty interest in the future development of the major oil and gas opportunity in Louisiana.
Lithium Exploration’s Blockchain efforts in the oil and gas industry are moving forward. The Company has been incubating a Blockchain concept, which will make it much easier and more transparent for investors who are not part of the oil and gas ecosystem to participate in investment opportunities.
Nonetheless, the Company is not spending any money on those efforts until after the completion of the royalty acquisition. Lithium Exploration is looking to partner with a couple of external companies to establish the Blockchain marketplace that it will manage.
Recently, Lithium Exploration announced that preparation and permitting was initiated at its oil project in SW Louisiana. The expectation is that the pad undergoing preparation will host the drilling of the first three target locations.
A joint team of internal and external geophysicists have prepared the locations. This team has identified these locations in a specific fault block, using the processed seismic data collected last year versus historical production from the field, and determined that these locations will be the most productive. The team has put a projection of 800K to 1.4M barrels of oil from this fault block that can be simultaneously extracted by drilling three wells at different depths.
Lithium Exploration Group, Inc. (LEXG), closed Monday's trading session at $0.0055, up 27.907%, on 995,902 volume with 18 trades. The average volume for the last 3 months is 163,757 and the stock's 52-week low/high is $0.003/$0.018899999.
DSG Global, Inc. (DSGT)
Epic Stock Picks, StockHideout, Stock Preacher, Penny Stocks Finder, SuperStockTips, Penny Stock Craze, SMS Penny Picks, eliteotc.com, WININGOTC, Wall Street Beauties, StockRockandRoll, The Observer, OTC Markets, PennyStockLocks.com, ResearchOTC, InvestorSoup, and Beacon Equity Research reported previously on DSG Global, Inc. (DSGT), and we report on the Company today, here at the QualityStocks Daily Newsletter.
DSG Global, Inc. is a technology development company whose shares trade on the OTCQB. The Company engages in the design, manufacture, and marketing of fleet management solutions for the golf industry, and also commercial, government, and military applications worldwide. DSG Global has historically concentrated on the golf industry. It has grown to become a leader in the Fleet Management category in the golf industry. DSG Global is based in Surrey, British Columbia.
The Company provides patented electronic tracking systems and fleet management solutions to golf courses. These allow for remote management of the course's fleet of golf carts, turf equipment, as well as utility vehicles. DSG is best known for its advanced GPS TAG System for golf cart and turf equipment fleet management.
DSG Global’s technology is installed in more than 10,000 vehicles on golf courses globally. The Company has an installed base of daily-fee and resort golf courses. Its cart-mounted Touch® display screens seamlessly deliver banner advertisements and full-motion videos while on the golf course.
Fundamentally, golf course operators manage their fleet of golf carts, turf equipment, and utility vehicles remotely, using DSG Global’s SaaS (Software as a Service) technology and advanced GPS hardware. DSG has acquired Impact Tournament Solutions, along with Impact’s team of experts, to run the Tournament Solutions Division of DSG Global.
DSG Global is currently branching into several new streams of revenue via programmatic advertising, licensing, and distribution. Additionally, the Company is expanding into Commercial Fleet Management and Agricultural applications. It realized record European sales in 2017 because of new installation contracts with top rated European Golf Management businesses. Furthermore, DSG Global is expanding into Raptor Single Rider Golf Car and 100E Fully Loaded Mullen Golf Cars, 2 and 4 seaters and Agricultural applications.
DSG Global has officially partnered with golf course video flyover company, STEADY MOTION. This is to bring the best interactive flyover videos to the golf sports industry. These flyover videos include professional, broadcast television quality audio narration, advanced color correction, and interactive course tours ready to be displayed on the DSG TOUCH screens and on golf course web portals.
Recently, DSG Global announced that it is introducing to the global market the first ever Infinity 12" High Definition display. This display is equipped with streaming music, video, Bluetooth, stock market and sports scores, and the top-graded flyovers in the nation, credit card tap availability, dual speakers and Programmatic Advertising.
Furthermore, last month, DSG Global announced that it has taken first steps to move towards exploring potential use cases, which it has identified for blockchain and its related technologies to be applied to the golf industry.
Mr. Robert Silzer, DSG Global’s Chief Executive Officer, stated, "Blockchain will definitely change the golf industry and DSG plans to play a leading role to bring this change to fruition. I believe this technology will revitalize the golf industry. It can build a new bridge between golf and the millennials and raise new enthusiasm for the sport. It can release tremendous value that is currently untapped."
DSG Global, Inc. (DSGT), closed Monday's trading session at $0.60, up 108.6957%, on 14,509 volume with 16 trades. The average volume for the last 3 months is 3,370 and the stock's 52-week low/high is $0.27000001/$10.3999996.
KinerjaPay Corp. (KPAY)
OTC Markets, InvestorsHub, MarketWatch, TradingView, Stockhouse, Marketbeat, and Barchart reported on KinerjaPay Corp. (KPAY), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Established in 2010, KinerjaPay Corp. focuses on operating a digital payment and e-commerce platform. The Company, through its wholly-owned subsidiary, PT Kinerja Pay Indonesia, enables consumers to "pay, play, and buy" via its secure website and mobile applications. KinerjaPay’s intention is to establish the Company as a leader in Indonesia's digital economy, with a specific emphasis on the middle- and low-income markets. KinerjaPay is based in Indonesia.
A digital payment and ecommerce platform, KinjerPay’s services are available through its mobile applications, and on its website at www.kinerjapay.com. The KinerjaPay platform provides a secure payment solution. In addition, it provides a developing virtual marketplace where participants can buy and sell products and services.
In May 2016, KinerjaPay entered into a partnership with Bitcoin Indonesia. This makes KinerjaPay the first e-commerce portal in Indonesia authorized to accept and transact Bitcoin across its platform. This enables account holders to convert the virtual currency to Indonesian Rupiah to pay their bills, transfer money, or make purchases in the Company's ecommerce market.
KinerjaPay offers several in-app services that cater to mobile users. These in-app services include an eWallet, social engagement, and digital entertainment related applications. Additionally, the Company is pursuing other e-commerce verticals. These include travel, fashion, gaming, and productivity applications.
Moreover, KinerjaPay has created a number of unique features designed to engage users. This includes an interactive gamification component that permits users to play and earn rewards while enjoying the benefits of shopping online. The Company is also providing users the convenience of making online payments of their utility bills, phone top-ups/data plans, insurance premiums, automobile loan instalments, and many other applications.
KinerjaPay plans to expand its digital ecommerce platform with the launch of KinerjaGames. It entered a long-term License Agreement with Ace Legends Pte. Ltd. (ACE). ACE is a Singapore-based game developer.
With this Agreement, in exchange for a $100,000 investment, KinerjaPay will become the exclusive, worldwide Game Publisher License for ACE games. The Company will also host all the games now published by ACE on its own KinerjaGames platform.
This past October, KinerjaPay announced its partnership with Uber Technologies, Inc. Uber is the worldwide smartphone-enabled 'Ride-Hailing' service.
With this partnership, Uber will grant KinerjaPay users an exclusive promotion code for first-time users, valid for four rides. Users can at first redeem the Uber/KinerjaPay promotion code by creating a new account on the Company's eCommerce platform or meeting a certain spending threshold with KinerjaPay's proprietary KinerjaMall service. User/clients can subsequently redeem their unique code directly in their KinerjaPay smartphone app to use the Uber service.
Recently, KinerjaPay announced that it has chosen Blockchain Industries, Inc. and Fintech Global Consultants to transition to a token payment platform. Blockchain Industries, in partnership with Fintech Global Consultants, will be guiding KinerjaPay in its transition from an electronic payment platform to a token payment platform.
KinerjaPay’s plan is to raise up to US $5 million from its imminent ICO (initial coin offerings). The ICO will be offered to institutional or private investors in the form of KCOIN, KinerjaPay's own proprietary virtual currency. With the ICO, KCOIN will be used as KinerjaPay's cryptocurrency on one of the largest cryptocurrency exchanges in Asia.
KinerjaPay Corp. (KPAY), closed Monday's trading session at $0.149, up 33.7522%, on 865,905 volume with 117 trades. The average volume for the last 3 months is 629,400 and the stock's 52-week low/high is $0.100100003/$0.949899971.
Provision Holding, Inc. (PVHO)
GrowthPennyStocks, Penny Stock General, Shiznit Stocks, HotStockProfits, PennyDoctor, Stock Beast, RedChip, PennyStockLocks.com, Epic Stock Picks, Equity Observer, Value Penny Stocks, Wolf of Penny Stocks, Small Cap Firm, OTCMagic, MicroCapDaily, and StockRockandRoll reported on Provision Holding, Inc. (PVHO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Provision Holding, Inc., by way of its subsidiary, focuses on the development and distribution of intelligent interactive three-dimensional (3D) holographic display technologies, software, and integrated solutions for consumer and commercial centered application. These are chiefly for advertising and product merchandising markets. The Company’s initial line of display systems has proven to be ideally suited for indoor and outdoor point-of-sale (PoS), merchandising, and PoS related advertising venues. Provision Interactive Technologies, Inc. is a subsidiary of Provision Holding. Provision Holding is based in Chatsworth, California.
Provision’s products include HoloVision displays and 3D Savings Center kiosks. These enable advertisers and customers to reach captive audiences in grocery stores, malls, convenience stores, gas stations, banks, as well as other retail sites. The Company’s proprietary 3D holographic display technologies give advertisers first-rate ability to direct customized content to a target audience.
Provision's 3D holographic display systems represent a unique technology. This technology provides the projection of full color, high-resolution videos into space detached from the screen, without any special glasses. The Company has completed the development and prototype of its latest 3D holographic display system, the HL50.
The HL50 is its largest Holovision™ product. The design of it is for exhibitions and special events. The HL50 uses Provision Interactive Technologies’ patented and award-winning 3D holographic technology. It comes complete. This includes a media player and the Company’s proprietary software, HoloSoft™. The HL50 can project visually stunning 3D holographic videos, detached from the screen, floating in space more than 40 inches outward.
This past June, Provision Interactive Technologies announced that the Company entered into a multi-year partnership agreement with Discount Drug Mart, Inc. This partnership agreement is to install Provision’s proprietary 3D Savings Center kiosks inside Discount Drug Mart stores. The agreement represents the next major retail partnership for Provision.
Prosperity Investments, under its Joyful ATM brand, has entered into an agreement with Provision Interactive Technologies to integrate its 3D holographic display and coupon redemption platform into Joyful ATMs to boost in-store engagement and purchases at point-of-sale (PoS).
Greater than 48,000 Joyful ATM units are planned to undergo deployment across the U.S. and in another 68 countries over the next 72 months, at locations including banks, retailers, convenience stores, gas stations, and government buildings. Via the partnership, the ATMs will project 3D holographic advertising messages to attract customers to the unit. Upon the customer approaching the unit, they can redeem coupons for the advertised products that can be used right away, driving enhanced PoS activity.
Provision Holding, Inc. (PVHO), closed Monday's trading session at $0.0089, up 27.1429%, on 317,200 volume with 11 trades. The average volume for the last 3 months is 158,808 and the stock's 52-week low/high is $0.0031/$0.0302.
WRIT Media Group, Inc. (WRIT)
SeriousTraders, Tip.us, Real Pennies, StocksToBuyNow, Pennystockmania, Great Penny Picks, and SmallCapVoice reported earlier on WRIT Media Group, Inc. (WRIT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
WRIT Media Group, Inc. is a diversified media and software business whose shares trade on the OTC Markets. The Company’s portfolio of wholly-owned businesses includes Front Row Networks; Amiga Games; Retro Infinity, Inc.; and Pandora Venture Capital. WRIT Media Group is headquartered in Los Angeles, California.
WRIT Media’s operations include digital currency software development, including trading platforms and Blockchain solutions, content production and distribution; and video game distribution by way of mobile platforms. Its Front Row Networks produces and distributes live event programming for international digital broadcast to movie theaters and online streaming.
WRIT’s Amiga Games is a software company. Amiga is restarting the Amiga brand through publishing retro video games on smartphones and tablets. WRIT’s Retro Infinity is a video game distribution site. It publishes video games from Amiga, Atari and other "retro" brands on contemporary smartphones, tablets and consoles.
Additionally, WRIT’s Pandora Venture Capital is a financial technology company. Pandora has an emphasis on its digital currency, Pelecoin, a new generation of digital currency, Blockchain technology solutions, and also the CrypFXPro trading platform. WRIT Media's proprietary CrypStock digital trading platform will provide the technology that will support the creation and trading platform for Pelecoin and other digital currencies.
WRIT Media Group plans to integrate its Pelecoin Blockchain technology into products and applications that can be used to make it as easy to spend digital currencies, cryptocurrencies, and Pelecoin, as it is to spend US Dollars. Through the Company’s acquisition of Pandora Venture Capital, WRIT assumed a skilled management team with backgrounds in payments, telecom, and digital currency.
Recently, WRIT Media Group announced a number of technology innovations within its Pelecoin cryptocurrency system. The Company plans over the next year to enhance its software platform through adding more features and by expanding its ecosystem through new products.
During the past several months, WRIT Media's development team has built the core functionality of its digital currency system. The Company now offers a new feature that enables users to mine four cryptocurrencies at the same time by employing Pelecoin's proprietary mining algorithm software. The core system is complete. The foundation is ready for Pelecoin to expand and become a strong platform suitable for broader adoption, with updated core features and extensive new ones for its ecosystem.
WRIT Media Group, Inc. (WRIT), closed Monday's trading session at $0.0179, up 43.20%, on 8,533 volume with 6 trades. The average volume for the last 3 months is 4,778 and the stock's 52-week low/high is $0.009999999/$0.100000001.
The QualityStocks Company Corner
- Youngevity International, Inc. (NASDAQ: YGYI)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- Green Hygienics Holdings Inc. (GRYN)
- Nightfood Holdings, Inc. (OTCQB: NGTF)
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)
- MustGrow Biologics Corp. (CSE: MGRO)
- Hemptown USA
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- Willow Biosciences Inc. (CSE: WLLW)
- Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
- Endonovo Therapeutics Inc. (ENDV)
Youngevity International, Inc. (NASDAQ: YGYI)
Youngevity International Inc. (NASDAQ:YGYI) announces the availability of an audio press release titled, “Smart Companies Finding Sweet Spot in Cannabis Processing, Manufacturing Opportunities.” To hear the CannabisNewsAudio version, visit: http://cnw.fm/da6zC. To read the full editorial, visit: http://cnw.fm/Qgk2J.
Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.
Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.
Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.
Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.
Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:
- Health and Nutrition
- Home and Family
- Food and Beverage
- Spa and Beauty
- Essential Oils
- Photo and scrapbooking
- Services for Home and Business
Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.
Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.
Youngevity International, Inc. (NASDAQ: YGYI), closed Monday's trading session at $5.23, up 2.9528%, on 75,240 volume with 598 trades. The average volume for the last 3 months is 102,558 and the stock's 52-week low/high is $3.56999993/$16.25.
- Youngevity Inc. (YGYI) Featured in CannabisNewsAudio Broadcast Featuring Potential Payoff in Back End of Cannabis
- Youngevity Inc. (YGYI) Featured in CannabisNewsWire Publication Discussing the CBD Industry’s ‘Sweet Spot’
- Youngevity International Inc.’s (NASDAQ: YGYI) Khrysos Industries Enters $19M CBD Water Soluble Isolate Supply and Processing Agreement
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) was featured today in the 420 with CNW by CannabisNewsWire. New data released by Nielsen shows that people who live in states where marijuana is legal snack more than their counterparts in states with prohibitionist laws. The uptick in the sales of snacks was noticed for sweet and well as salty snacks. This study suggests that legalizing recreational marijuana can create a boom for the confectionary and snack segments of the food and beverage industry in the U.S.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Monday's trading session at $2.7773, up 2.6159%, on 28,585 volume with 68 trades. The average volume for the last 3 months is 63,328 and the stock's 52-week low/high is $2.51999998/$6.00810003.
- 420 with CNW – New Data Reveals Cannabis Legalization Increases Rates of Snacking
- PLUS Products Launches Rebrand of its Cannabis Infused Edibles Line
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Named ‘Premier Edibles Brand to Watch’ by Technical420
Green Hygienics Holdings Inc. (GRYN)
Green Hygienics Holdings Inc. (OTCQB: GRYN) (“GRYN" or the “Company"), an innovative, full-scope, science-driven premium cannabis cultivation and branding enterprise, is pleased to announce it has secured licenses for the processing of hemp in the state of North Carolina. The licenses were granted to the Company’s newly formed subsidiary, Coastal Labs North Carolina LLC, by the North Carolina Industrial Hemp Commission. The North Carolina Department of Agriculture and Consumer Services (Food and Drug Division) provides guidance regarding the manufacture and sale of products that contain CBD.
Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.
The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.
Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.
Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.
Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.
The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.
Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.
Green Hygienics Holdings Inc. (GRYN), closed Monday's trading session at $1.57, up 6.0811%, on 19,838 volume with 33 trades. The average volume for the last 3 months is 17,279 and the stock's 52-week low/high is $0.100100003/$1.80999994.
- Green Hygienics Holdings Inc. Secures License for Processing Hemp in the State of North Carolina
- Green Hygienics Holdings Inc. (GRYN) Positioned to Profit as New Hemp Regulations Facilitate Widespread Cultivation in California
- Green Hygienics Holdings Inc. (GRYN) Increases Presence in California and Michigan with Licenses to Cultivate Industrial Hemp
Nightfood Holdings, Inc. (OTCQB: NGTF)
Nightfood, Inc. (OTCQB: NGTF), the fast-growing ice cream company addressing America’s $50 billion-dollar nighttime snacking problem, announced today that Nightfood was featured in the July issue of Oprah Magazine, the latest instance in a long series of prominent coverage by major consumer media outlets.
Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.
Nightfood Ice Cream
Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.
Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.
With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.
Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.
More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.
Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.
Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.
Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.
Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.
MJ Munchies, Inc.
MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.
Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.
Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.
Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.
CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.
The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.
Nightfood Holdings, Inc. (NGTF), closed Monday's trading session at $0.47, up 0.021281%, on 67,802 volume with 44 trades. The average volume for the last 3 months is 199,981 and the stock's 52-week low/high is $0.160099998/$0.920000016.
- Nightfood® Sleep-Friendly Ice Cream Featured in Oprah Magazine July Issue
- Nightfood Holdings Inc. (NGTF) Beyond Food-Organic and Healthier Food Trends 2019
- Nightfood and All-World NFL Cornerback Richard Sherman Team Up to Launch Custom Ice Cream Flavor
Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)
Siyata Mobile Inc. (TSX-V:SIM / OTCQX:SYATF) is pleased to announce that it has received an initial purchase order of $360,000 through a leading taxi technology distributor to equip taxi cabs in Israel with its innovative 4G/LTE CP250, an all-in-one dash mounted communications device.
Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.
Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.
Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.
The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.
Siyata is headquartered in Montréal, Québec, Canada.
Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.
The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.
The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.
CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.
Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.
CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.
Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.
Siyata Mobile Inc. (SYATF), closed Monday's trading session at $0.3749, up 0.321113%, on 3,000 volume with 2 trades. The average volume for the last 3 months is 63,172 and the stock's 52-week low/high is $0.288599997/$0.446249991.
- Siyata Mobile Receives $360,000 Purchase Order to Equip Taxis with CP250 All-in-One Communications Device
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Receives $700K Single End-Use Customer Purchase Order to Equip Mobile Workforce, Vehicle Assets
- Siyata Mobile Receives US Purchase Order for its Uniden® UV350 4G/LTE In-Vehicle Device Valued at $925,000
MustGrow Biologics Corp. (CSE: MGRO)
The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp..
MustGrow Biologics Corp. (CSE: MGRO), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and biofertilizers for the cannabis industry, has a mountain of good news to share with its stakeholders. MustGrow recently issued a number of strategic press releases that illustrate the significance of the company’s signature, patented products and the potential impact they are expected to have on the cannabis industry.
MustGrow Biologics (CSE: MGRO) is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.
Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients?(http://nnw.fm/Qkz21).?For the past 50 years,?nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical?formulations.
MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://nnw.fm/3HGuT), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.
MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.
MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.
Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:
- 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
- 55 percent tomato crop yield increase
- 95 percent control of Pythium root rot in lettuce fields
- 70 percent reduction in Verticillium root severity in cucumbers
- Market Opportunity
MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers.?MustGrow’s?potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.?
Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated?$9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.??
MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.
President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries.? Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.
Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.
COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.
Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis?(TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.
Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.
CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.
MustGrow Biologics Corp. (CSE: MGRO), closed Monday's trading session at $0.32, up 1.59%, on 83,395 volume. The average volume for the last 3 months is 175,762 and the stock's 52-week low/high is $0.25/$0.699999988.
- MustGrow Biologics Corp. (CSE: MGRO) Targets Cannabis Industry with Biopesticide R&D Program Utilizing Signature, Patented Products
- MustGrow Biologics Corp (CSE: MGRO) Appoints Senior Executive with Extensive Regulatory Prowess to Board of Directors
- MustGrow Biologics Corp. Featured in Exclusive NetworkNewsWire Broadcast
The QualityStocks Daily Newsletter would like to spotlight Hemptown USA.
Hemptown USA, a privately held company headquartered in Southern Oregon’s Emerald Triangle, is currently focusing on its rapid, vertically integrated growth within the lucrative cannabis industry. As a part of this strategy, the company announced the acquisition of assets comprising the FDA licensed, cGMP-certified operating nutraceutical business of the Kirkman Group (http://ibn.fm/GaNUI).
Hemptown USA, headquartered in Central Point, Oregon, is a proven grower of full-spectrum hemp biomass grown using premium seed genetics that contain less than 0.3% THC and exceptionally high cannabinoid (CBD) content of up to 20%. The company's "soil to oil" methodology combines seasoned professionals working in hand-picked agricultural microclimates located in Oregon's famed Emerald Triangle, Kentucky and Colorado.
Hemptown has exclusive rights to 1 million rare CBG (cannabigerol) seeds genetically programmed to yield from 15% to 20% full-spectrum non-intoxicating cannabinoids. As a result of a long-standing relationship with the one of the world's most respected cannabis breeding companies – Oregon CBD Seeds – Hemptown is positioned to be a leading CBG producer in the U.S. in 2019 and beyond.
In 2018 Hemptown's harvest from its Oregon hemp farm was 150,000 pounds of full-spectrum biomass with CBD content hovering around 17%. 2018 harvest revenue expected to range from $8.1 million to $12.6 million. The company is scaling up operations in 2019 to meet market demands and projects it will reap over 1,000,000 pounds. By 2020, Hemptown projects potential revenues in the $100 million to $200 million range are possible once additional farming operations are at full strength.
By 2020, Hemptown anticipates it will have more than 3,000 acres in several states dedicated to hemp farming. Expansion plans include increasing in-house extraction capabilities to boost profit margins by providing additional CBD and CBG isolates and distillation services. Development of business-to-business channels as well as new products and formulations for the direct-to-consumer market, along with several strategic acquisitions, are also key to Hemptown's growth strategy.
Hemptown plans to expand distribution and growing operations globally through strategic partnerships and development of contracts with leading Fortune 500 brands in European markets. The company intends to grow its IP portfolio by developing a proprietary water-soluble cannabinoid delivery system. Not to be confused with water-compatibility, water-soluble cannabinoids combine seamlessly with other liquids, have a superior shelf life, and deliver dramatically increased efficacy to the consumer.
Hemptown's first in-house branded product line combines the inspiring strength found in the unbridled nature that surrounds the company's original hemp farm in the Siskiyou Klamath region of Oregon. Sisku is set to redefine the cannabinoid packaged goods space with an elegant look, clean feel and potent, reliable efficacy.
Custom product lines can also be created for any product manufacturer as Hemptown brings GMP and ISO accredited processing facilities online in 2019. Together with Oregon CBD Seeds and Hemptown's product sciences team, Hemptown will be able to create custom, proprietary full-spectrum CBD and CBG oils and pure isolates.
Company Chairman Rod Wolterman founded Hemptown's Oregon operations in 2016. He has extensive experience in the cannabis sector having been active within the space since 1998. Wolterman has also acted as a private equity investor in numerous medical marijuana dispensaries and cultivation operations in southern California.
CEO John Cummings has over 20 years of experience in finance, marketing, sales and project management. He led the compliance and special projects efforts for Kings Garden, one of the largest vertically integrated operators in California. Cummings also spent a year in Europe launching the continent's first GMP and ISO-accredited cultivation and manufacturing facility.
Dr. Gordon Chiu is chief science officer for Hemptown USA. He has more than 15 years of combined domestic and international experience in biomedical, chemical, cosmetic, medical and technology industries. A graduate of Rensselaer Polytechnic Institute with a master's degree from Seton Hall University, Chiu is leading Hemptown's cannabinoid research team and is responsible for filing IP patents, specifically in the areas of water-solubility, bioavailability and peptide sequencing.
- Hemptown USA Acquires Leading Nutraceutical Manufacturing Facility
- Keeping Hemp Production Costs Low through Technology: How Hemptown USA is Changing the Lucrative Market
- Hemptown USA Enters Consumer Packaged Goods Space through Kirkman Group Acquisition
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) was featured today in the 420 with CNW by CannabisNewsWire. New data released by Nielsen shows that people who live in states where marijuana is legal snack more than their counterparts in states with prohibitionist laws. The uptick in the sales of snacks was noticed for sweet and well as salty snacks.
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Monday's trading session at $6.27, off by 0.947867%, on 931,259 volume with 3,689 trades. The average volume for the last 3 months is 1,120,273 and the stock's 52-week low/high is $2.97000002/$8.43999958.
- 420 with CNW – New Data Reveals Cannabis Legalization Increases Rates of Snacking
- Brand Innovation is the Key to Becoming a Leader in the Cannabis-Infused Beverage Industry
- Top Five Must-Know Hemp Stocks for 2019
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)
Canopy Rivers Inc. (TSXV: RIV) (OTC: CNPOF) is pleased to announce that its 49%-owned joint venture, PharmHouse Inc. ("PharmHouse"), has received a cultivation licence from Health Canada. PharmHouse will be immediately commencing operations in 190,000 sq. ft. of licensed nursery infrastructure and plans to ramp up the entire 1.3 million sq. ft. ultramodern greenhouse before the end of 2019 to deliver low-cost and high-quality cannabis and cannabis derivative products to the Canopy Rivers ecosystem of partners, both domestically and internationally.
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.
Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.
Canopy Rivers’ expanding portfolio includes:
- Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
- CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
- Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
- James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
- LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
- PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
- Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
- Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
- Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
- TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
- Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.
As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.
Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.
Canopy Rivers Inc. (CNPOF), closed Monday's trading session at $2.2645, off by 1.5435%, on 78,172 volume with 177 trades. The average volume for the last 3 months is 108,088 and the stock's 52-week low/high is $1.75/$7.30155992.
- Canopy Rivers' Flagship PharmHouse JV Licensed By Health Canada
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Releases Q4, Fiscal Year 2019 Financial Highlights; Provides Corporate Update
- Investor Ideas Potcasts, Cannabis News and Stocks on the Move
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) produces farm-grown, premium, certified-organic medical cannabis in small batches in Hamilton, Ontario, and Valleyfield, Quebec. Even in the midst of an expanding supply gap, TGOD’s officials know that time spent cultivating product through clean, natural and sustainable methods is worth the wait, and attention to detail leads to an outstanding product that meets the highest standards for organic cultivation. Dedication to that knowledge shows in every step of the company’s production process.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at firstname.lastname@example.org
The Green Organic Dutchman (OTC: TGODF), closed Monday's trading session at $2.3861, off by 3.0041%, on 549,196 volume with 640 trades. The average volume for the last 3 months is 518,328 and the stock's 52-week low/high is $1.60699999/$7.89379978.
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Committed to Maintaining Quality, Meeting Demand
- NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Aims to Establish Significant Presence in Global Hemp, CBD Market
- With 10,000 Licenses Issued, California Reflects the Growing Power of Hemp
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Supreme Cannabis (TSX: FIRE) (OTCQX: SPRWF). The old Aesop axiom advises to be vigilant, for you can be known by the company you keep. If that's the case, then Supreme Cannabis must feel pretty good, as it has surrounded itself with household names in the burgeoning cannabis industry, albeit in-house, through partnerships or association.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Monday's trading session at $1.08, off by 2.3596%, on 317,704 volume with 432 trades. The average volume for the last 3 months is 317,066 and the stock's 52-week low/high is $0.850000023/$2.03999996.
- Supreme Cannabis: At the Epicenter of Premium Products -- CFN Media
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Shows Impressive Domestic, International Growth
- Supreme Cannabis to acquire Truverra as it prepares for Legalization 2.0 and Global Medical Markets
Willow Biosciences Inc. (CSE: WLLW)
CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication of an article covering Willow Biosciences (CSE: WLLW) (OTC: CANSF) and the fascinating world of biosynthetically produced cannabinoids.
Willow Biosciences Inc. (CSE: WLLW) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.
The company is headquartered in Calgary, Alberta, Canada.
Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.
The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.
Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.
Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.
Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.
The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.
Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.
The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.
The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.
The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.
Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.
President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.
Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.
Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.
Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.
Willow Biosciences Inc. (CSE: WLLW), closed Monday's trading session at $0.85, off by 1.16%, on 17,580 volume. The average volume for the last 3 months is 60,702 and the stock's 52-week low/high is $0.76999998/$5.25.
- Synthetic Cannabinoids: The New Age of Medical Marijuana-- CFN Media
- NetworkNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Employs Proprietary Biosynthetic Processes to Develop Ultra-Pure CBD
- Willow Biosciences Inc. (CSE: WLLW) Developing Biosynthesis Platform for Production of Low-Cost, Pharmaceutical-Grade CBD
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that through a wholly owned U.S. subsidiary, the Company has finalized its investment into Applied Cannabis Sciences of New Jersey ("ACS"), a New Jersey-based medical vertically integrated applicant, previously announced as a letter of intent (press release dated April 15, 2019).
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF), an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements' expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.
Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company.
- Investment and funding for rapid growth
- Vertical integration solutions
- Construction, design and/or optimization of indoor or outdoor cultivation facilities
- Reputation management & influencer outreach
- Branding and Packaging
- Social Media and Media outreach
With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.
Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.
Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.
Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company "maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S."
Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree's working capital.
Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).
Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.
Chemistree Technology Inc. (CHMJF), closed Monday's trading session at $0.2248, off by 0.925518%, on 41,778 volume with 32 trades. The average volume for the last 3 months is 96,090 and the stock's 52-week low/high is $0.189999997/$0.605000019.
- 420 with CNW – Church of England Starts Investing in Marijuana
- 420 with CNW – Colorado Governor Unveils Online Tool to Track Cannabis Achievements
- 420 with CNW – New York Marijuana Decriminalization Expands as Full Legalization Fails
Endonovo Therapeutics Inc. (ENDV)
Endonovo Therapeutics Inc. (OTCQB: ENDV) is delivering a safe and reliable alternative to opioid medications for the management of pain. The global post-operative pain management market is anticipated to grow at a CAGR of 5.4 percent through 2023, with an increasing number of surgeries worldwide and a growing prevalence of different diseases as major factors for the growth of the market, according to a Market Research Future report (http://nnw.fm/TfD33). An increasing aging population around the globe will also has a considerable impact on the growth of the market, the report underlines.
Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders.
In accord with its mission to transform the field of medicine through innovation, Endonovo’s bioelectric Electroceutical™ devices harness bioelectricity to restore key electrochemical processes that initiate anti-inflammatory processes and growth factors in the body necessary for healing to rapidly occur. Endonovo’s current portfolio of commercial-stage devices address chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke.
SofPulse® Electroceutical ™ Therapy is an easy-to-place, non-invasive device that delivers pulsed electromagnetic frequencies to enhance post-surgical recovery. Used as a stand-alone therapy or integrated into any treatment protocol, SofPulse®’s?targeted?pulsed electromagnetic field?(tPEMF)?transmits gentle pulses to the tissue causing a positive biological effect to help reduce swelling and accelerate the body’s natural recovery process. The low levels of electromagnetic fields are completely safe and are 1000 times lower than those emitted by a mobile phone.?
Because SofPulse® lessens the pain of post-surgical recovery, the patient requires far less prescription medications, thereby minimizing or eliminating the adverse side effects of narcotics and anti-inflammatory medication. Studies have shown a greater than 2.2-fold reduction in narcotic use over the first 48 hours post-procedure. Patients with less pain and medication may move around sooner, which further stimulates the body’s natural response to healing.
Endonovo’s Electroceutical™ Therapy is cleared by the U.S. Federal Drug Administration (“FDA”) for the palliative treatment of pain and post-surgical edema (swelling) and is CE-marked in the European Economic Area (“EEA”) for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. The Centers for Medicare and Medicaid Services (“CMS”) has also certified Electroceutical™ Therapy for the treatment of chronic wounds.
Alan Collier, Chairman and CEO
Alan Collier has more than 25 years of experience in corporate finance, IP development, telecommunications and technology, with a concentration in healthcare and technology over the past five years. Collier has served as CEO and director of IP Resources International Inc., where he was instrumental in developing a platform the for the licensing and acquisition of life science and technology companies. He has held numerous board and executive positions throughout his career in the telecommunications, technology, specialty finance, corporate finance and healthcare industries. Collier has previously held FINRA Series 7, 79, 63 and 24 licenses.
Michael Scott Mann, President
Michael Scott Mann has over 30 years of experience in merger and acquisitions and operational management. In 2008, Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics Inc., and led the company to become listed on the OTCBB in 2012. He was the founder, president and CEO of Frankfurt-listed U.S. Debt Settlement Inc. (USDS), where he implemented a growth by acquisition strategy.?
Don Calabria, Chief Operating Officer
Don Calabria has over 20 years of leadership and experience in national business operations to emerging growth companies, mergers and acquisitions, finance and business development. Calabria holds an MBA from the Graziadio School of Business and Management at Pepperdine University and a bachelor’s degree from Arizona State University.
Nevena Zubcevik, Chief Medical Officer
Nevena Zubcevik, D.O., MSPT, ATC, on July 1, 2019, will lead Endonovo’s medical and clinical strategy, including the development and regulatory matters and new business development. Zubcevik, a licensed physician and educator, has more than 24 years of experience in the medical field and was an attending physician at Harvard Medical School/Partners Healthcare in the physical medicine and rehabilitation department.
Steven Ford, Vice President of Marketing
Steven Ford has 25 years of experience in the field of medical devices, including experience in sales management, product management, product development, business development and research & development at companies such as Baxter, CR Bard, Ethicon, Allergan, Mallinckrodt Pharmaceuticals and Alphatec Spine. Throughout Ford’s career, he has led and participated on over 75 product development teams and has launched over 50 medical devices globally. Ford is an innovative problem solver and has many patents in the areas of hemostasis, sealing and tissue reconstruction. Most recently, Steve was the U.S. vice president of marketing for Biom’up where he was a co-lead on the high-profile successful launch of their surgical hemostat HEMOBLAST Bellows. Steve holds a bachelor’s degree in marketing from California State University.
David Clark, Vice President of Sales
David Clark has extensive surgical device commercial experience which includes 25 years in the surgical device industry with leading companies including Medtronic and Baxter Healthcare. Most recently, Clark was the U.S. executive vice president of sales for Biom’up where he was a co-lead in the high-profile successful launch of their surgical hemostat HEMOBLAST. As part of the launch, he built and led the U.S. sales team which included over 200 in-direct sales representatives and direct commercial leadership. During his 15 years with Baxter, the BioSurgery Division grew from a small revenue business into a major market player in the advanced hemostasis space with products such as FloSeal and Tisseel. Clark has a bachelor’s degree in economics from Rutgers University.
Roc Alan McCarthy, Scientific Advisory Board Member
Roc Alan McCarthy, D.O, will help Endonovo continue to advance its clinical pipeline and contribute to the strategic and clinical development oversight of the company. McCarthy is a urologist in North Carolina, currently serving as the robotic surgeon and chairman of the robotics committee at the New Hanover Regional Medical Center.
Endonovo Therapeutics Inc. (ENDV), closed Monday's trading session at $0.0116, off by 3.9735%, on 7,347,335 volume with 125 trades. The average volume for the last 3 months is 6,270,634 and the stock's 52-week low/high is $0.008999999/$0.066100001.
- Endonovo Therapeutics Inc. (ENDV) Delivering Safe Patient Recovery Tech as Alternative to Traditional Opioid Pain Management Solutions
- Endonovo Therapeutics Appoints Dr. Peter Novak to its Scientific Advisory Board
- Endonovo Therapeutics Inc. (ENDV) Adds National Leader to Scientific Advisory Board
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) 420 with CNW – Senate Could Hold Hearings on Cannabis Banking Later this Month
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Releases Q4, Fiscal Year 2019 Financial Highlights; Provides Corporate Update
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) 420 with CNW – Colorado Governor Unveils Online Tool to Track Cannabis Achievements
- ChineseInvestors.com (CIIX) Provides Premier Market Data Via Unique Website
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green Holdings Inc. (CSE: CVGR) Retail Arm Expands Reach
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Reports Strong Attendance at Signature Fun Runs
- Earth Science Tech, Inc. (ETST) Subsidiary Establishes Position as Global Leader in CBD Industry
- Endonovo Therapeutics (OTCQB: ENDV) Delivering Safe Patient Recovery Tech as Alternative to Traditional Opioid Pain Management Solutions
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Receives Order of QuadSight™ Prototype from Leading Japanese Tier One Supplier
- Genprex Inc. (NASDAQ: GNPX) Provides Update on Lead Drug Candidate for Treatment of Non-Small Cell Lung Cancer
- Geyser Brands Inc. (TSX.V: GYSR) Appoints Seasoned Life Sciences Executive to Board of Directors
- Golden Developing Solutions, Inc. (DVLP) Leading the Way with Premier CBD Products, Ancillary Software
- Imaging3, Inc. (IGNG) Subsidiary Enters LOI with Dogwood Management Group, Inc.
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Featured in CannabisNewsWire Publication Discussing Mainstream Retailers Making Room for CBD
- Green Hygienics Holdings Inc. (GRYN) Positioned to Profit as New Hemp Regulations Facilitate Widespread Cultivation in California
- Hemptown USA - Keeping Hemp Production Costs Low through Technology: How Hemptown USA is Changing the Lucrative Market
- INmune Bio, Inc. (NASDAQ: INMB) Innovative Drug Candidate Targets Neuroinflammation to Treat Alzheimer’s Disease
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Swiftly Expanding Throughout the US
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) 420 with CNW – Study Finds Legalized Recreational Cannabis a Danger to Alcohol, Not Tobacco
- Marijuana Company of America Inc. (MCOA) 420 with CNW – Study Finds Legalized Recreational Cannabis a Danger to Alcohol, Not Tobacco
- MustGrow Biologics Corp (CSE: MGRO) Appoints Senior Executive with Extensive Regulatory Prowess to Board of Directors
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) Acquires 49% Interest in Budding Cannabis Industry Disruptor
- Nightfood, Inc. (OTCQB: NGTF) Beyond Food-Organic and Healthier Food Trends 2019
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) One of Canadias Leading Licensed Cannabis Producers, Expanding Capacity Even Further
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) President Issues Letter to Shareholders
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Achieves Key Milestone of Form 10 Registration Statement Effectiveness
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Launches Rebrand of its Cannabis Infused Edibles Line
- Pressure BioSciences Inc. (PBIO) Delivers Custom Built, Proprietary Ultra Sheer Technology Instrument to Ohio State for Food Safety Research
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Holds Favorable Position as Rising EV Market Boosts Lithium Demand Worldwide
- Sharing Services Global Corporation (SHRG) Strategically Positioned for Shift in Workforce, Retail Industry
- SinglePoint, Inc. (SING) Direct Solar Shaking Up Industry with Rocket Mortgage Model -- CFN Media
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Receives $700K Single End-Use Customer Purchase Order to Equip Mobile Workforce, Vehicle Assets
- Spectrum Global Solutions, Inc. (SGSI) Enters Definitive Agreement with German Technology Company
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Announces Plans to Launch BioNatural Oil Products Under CALIBER Brand
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Breaks Ground for Its Direct Lithium Extraction Demonstration Plant
- Sugarmade, Inc. (SGMD) Staying Ahead of Curve for Anticipated Record Crop in 2019
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Shows Impressive Domestic, International Growth
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Aims to Establish Significant Presence in Global Hemp, CBD Market
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Continues Testing of TherOZap(TM) Technology Against the Zika Virus
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Lifestyle Delivery Systems Inc. Announces a Termination of Exclusive Agreement to Amalgamate Lifestyle Delivery Systems Inc. with TransCanna Holdings Inc.
- Trxade Group Inc. (TRXD) Proprietary Web-Based TRxADE Platform Targets Nation’s Independent Pharmacy Marketplace
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) 420 with CNW – Group Announces Intention to Initiate Ballot Measure to Legalize Recreational Marijuana in Arkansas
- VPR Brands, LP (VPRB) Announces New HoneyStick – Elf with Adjustable Intensity Settings
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Doubles Retail Reach through Dillard’s Launch
- Willow Biosciences Inc. (CSE: WLLW) Employs Proprietary Biosynthetic Processes to Develop Ultra-Pure CBD
- Youngevity International, Inc. (NASDAQ: YGYI) Featured in CannabisNewsWire Publication Discussing the CBD Industry’s ‘Sweet Spot’
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.